Human Capital Benefits participated in the AbbVie National Private Payer Advisory Board meetings in Toronto on October 22, 2019 at the InterContinental Hotel. The objective of the meeting was to gain feedback/recommendations from a handful of select advisors, pharmacist and Insurer drug practice leaders on both product and policy issues that AbbVie faces in order [...]
With the drug plan landscape continuing to shift and the idea of sustainability hanging in the balance, managing costs and value for the plan members is what is ultimately at risk. The 2019 Canadian Leadership Council on Drug Plan Partnerships recently hosted a roundtable discussion on the drug benefit and how it is an ongoing [...]
Canadians currently pay some of the highest drug prices in the world. We pay close to 25% more than the median price than people in other developed countries for the exact same drugs; only United States and Switzerland pay more. Thus, the Canadian Government decided that something had to be done to contain costs. In [...]
The use of Patient Choice (manufacturer copay assistance/coupon cards) is gaining traction. By using these discount cards, plan members can greatly reduce or eliminate their out of pocket expenses for certain brand drugs. Benefit plans that are structured appropriately will force the drug manufacturer to absorb the additional costs of the brand drug (often 5X [...]
The Sanofi Canada Healthcare Survey is an annual report that strives to shed light on topics including workplace wellness, health concerns and the impact of chronic disease. The report tries to identify and address the changes needed from both plan members and sponsors for a healthy workforce. This annual report surveyed 1,505 plan members and [...]
